The latest thoracic oncology news
The Food and Drug Administration granted accelerated approval to pralsetinib for adult patients with metastatic…
Immune cells called ‘natural killer’ (NK) cells could be a powerful weapon for fighting lung…
‘Social smokers’ are more than twice as likely to die of lung disease and more…
Cancers gain and lose large sections of chromosomes in some of their cells but not…
Researchers in Spain have identified a non-coding RNA molecule that helps lung cancer cells proliferate…
For patients with non-small cell lung cancers (NSCLC) marked by RET gene fusions, the targeted…
It was announced that the U.S. Food and Drug Administration (FDA) has accepted the New…
The combination of first-line nivolumab and ipilimumab demonstrated an improvement of overall survival for patients…
The interim analysis of ORIENT-11, a phase III double-blind randomised trial has shown a nearly…
Patients with non-small cell lung cancer (NSCLC) carrying anaplastic lymphoma kinase (ALK) gene alterations who…